TCR2 Therapeutics | Results Presentation Deck | 34 slides · page 32 of 34
Uses multiparameter immunofluorescence to visualize tumor markers (PanCK), T cells (CD3), TAMs (CD68), and inhibitory ligands (CD155, PD-L1).
Regulatory filing · before_after · diagnose_problem · balanced density
Slide locked Sign in to view
Slide schematic 4/4
image 1/1 paragraph 1/1 title 2/2
Components 4
infographic paragraph headline subtitle
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1